Citalopram

7 trials 4 recruiting NNeurology/Psychiatry

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

2 Completed trials

6 Sponsors

12 Countries

Phase III

Phase II/III

Phase III/IV

Phase IV

Phase III: 3 Phase II/III: 1 Phase III/IV: 1 Phase IV: 2

Sponsors using this IMP

Universitair Medisch Centrum Utrecht 2 Amsterdam UMC Stichting 1 Otsuka Pharmaceutical Development And Commercialization Inc. 1 Region Hovedstadens Psykiatriske 1 Sygehus Lillebaelt Vejle Sygehus 1 UZ Leuven 1

All trials

7 total

Feasibility of short-term temporary discontinuation of serotonin reuptake inhibitors in patients planned for hip or knee arthroplasty Not authorised

2023-509988-24-00 Phase III/IV 1 country Sygehus Lillebaelt Vejle Sygehus
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared… Recruiting

2023-506605-19-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder c… Recruiting

2023-506617-21-00 Phase III 5 countries Universitair Medisch Centrum Utrecht
The DEXA-PSYCH Study: Dexamethasone Repurposing for Moderate to Severe Depression - A Double-Blind, Randomized, Parallel-Group, Placebo-Cont… Recruiting

2022-501428-45-00 Phase III 1 country Region Hovedstadens Psykiatriske
Citalopram for reflux hypersensitivity and functional heartburn Recruiting

2024-517019-57-00 Phase IV 1 country UZ Leuven
Protocol Lay Person Short Title: A Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment o… Ended

2022-500538-27-00 Phase II/III 6 countries Otsuka Pharmaceutical Development And Commercialization Inc.
Effect of citalopram on chest pain in patients with achalasia. Ended

2024-517701-81-01 Phase IV 1 country Amsterdam UMC Stichting

Showing 1–7 of 7 trials

← All drugs A–Z